JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32396

Anti-Estrogen Receptor alpha (phospho S118) 抗体 [E91]

Anti-Estrogen Receptor alpha (phospho S118) antibody [E91]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • Lab Essentials
  • Advanced Validation
  • 詳細を見る

4

(2 Reviews)

|

(26 Publications)

Rabbit Recombinant Monoclonal Estrogen Receptor alpha phospho S118 antibody. Suitable for Dot, WB, ICC/IF, ChIC/CUT&RUN-seq and reacts with Synthetic peptide, Human samples. Cited in 26 publications.

別名を表示する

ESR, NR3A1, ESR1, Estrogen receptor, ER, ER-alpha, Estradiol receptor, Nuclear receptor subfamily 3 group A member 1

9 Images
Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

Immunocytochemistry/ Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma cell line) cells labeling Estrogen Receptor alpha (phospho S118) with unpurified ab32396 at 5 μg/ml (1/200 dilution). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. ab150077, an AlexaFluor®488 Goat anti-Rabbit was used as the secondary antibody at 2 μg/ml (1/1000 dilution). ab195889, Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain at 2.5 μg/ml (1/200 dilution). DAPI nuclear counterstain.
Confocal image showing the signal increased after EGF (100ng/ml, 5 min) treatment and decreased after Lambda Protein Phosphatase treatment (31°C for 2 hours).

Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

Immunocytochemistry/ Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma epithelial cell) treated with EGF (100ng/ml, 5min) and treated with Lambda Protein Phosphatase 31℃ for 2h cells labeling Estrogen receptor alpha (phospho S118) with purified ab32396 at 1 : 200 dilution (8.9μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

Immunofluorescent staining of (A) untreated and (B) Phosphatase-treated MCF-7 cells using unpurified ab32396.

Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • WB

Supplier Data

Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

All lanes:

Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (ab32396) at 1/1000 dilution

Lane 1:

MCF7 cell lysate (untreated)

Lane 2:

MCF7 cell lysate (treated with b-Estradiol and EGF)

Predicted band size: 66 kDa

Observed band size: 60 kDa

false

Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • WB

Supplier Data

Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (ab32396) at 1/1000 dilution

Lane 1:

MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 15 µg

Lane 2:

MCF-7 (Human breast adenocarcinoma epithelial cell) treated with epidermal growth factor whole cell lysates at 15 µg

Lane 3:

MCF-7 (Human breast adenocarcinoma epithelial cell) treated with epidermal growth factor whole cell lysates, then the membrane was incubated with phosphatase at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 66 kDa

Observed band size: 60 kDa

false

Exposure time: 5s

ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 MCF7 (Human breast adenocarcinoma epithelial cell) cells treated with phenol red free medium and 5% charcoal stripped FBS for 3 days than treated with β-estradiol (10 nM 45 min) and 5 µg of ab32396 [E91]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 MCF7 (Human breast adenocarcinoma epithelial cell) cells treated with phenol red free medium and 5% charcoal stripped FBS for 3 days than treated with β-estradiol (10 nM 45 min) and 5 µg of ab32396 [E91]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 MCF7 (Human breast adenocarcinoma epithelial cell) cells treated with phenol red free medium and 5% charcoal stripped FBS for 3 days than treated with β-estradiol (10 nM 45 min) and 5 µg of ab32396 [E91]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

Dot Blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)
  • Dot

Unknown

Dot Blot - Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] (AB32396)

Dot blot analysis of Lane 1 : Estrogen Receptor alpha (pS118) phospho peptide and Lane 2 : Estrogen Receptor alpha non-phospho peptide labeling Estrogen Receptor alpha (phospho S118) with unpurified ab32396 at 1/1000 dilution. 5% NFDM/TBST was used as the diluting and blocking buffer. ab97051, Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated was used as the secondary antibody at 1/100000 dilution. Exposure time : 3 minutes.

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-Estrogen Receptor alpha (phospho S118) antibody [E91] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

E91

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

Dot, WB, ChIC/CUT&RUN-seq, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

This antibody only detects ER alpha phosphorylated on Serine 118.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/200", "ICCIF-species-notes": "<p><strong>For unpurified use at 1/50 - 1/100 dilution. </strong></p>", "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "<p></p>" }, "Synthetic peptide": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/1000", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "ChICCUTRUNseq-species-checked": "notRecommended", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "" } } }

製品の詳細

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Estrogen Receptor alpha also known as ERα or ESR1 is a nuclear receptor that acts as a transcription factor when activated by its ligand estrogen. Its molecular weight is approximately 66 kDa. ERα is expressed in various tissues such as breast tissue endometrium and ovarian cells as well as some areas of the central nervous system. The ERα protein binds to specific DNA sequences called estrogen response elements to regulate the transcription of target genes. Tools like ER alpha ELISA and assays using alpha peptides help to study this receptor.
Biological function summary

ERα plays a significant role in the regulation of estrogen signaling. Estrogens binding to ERα activate the receptor which can form a homodimer or heterodimer complex with other proteins like coactivators or corepressors. This complex then modulates the transcription of genes involved in cell growth proliferation and differentiation. ERα is closely linked with processes like reproductive tissue development and maintenance.

Pathways

ERα is involved in the estrogen signaling pathway and the cell cycle regulation pathway. In the estrogen signaling pathway ERα works together with proteins such as coactivators which enhance gene transcription and corepressors which can inhibit transcription. In the context of cell cycle regulation ERα's interactions with other cell cycle proteins help control cell division and proliferation linking ERα activity to the progression through different stages of the cell cycle.

ERα's dysregulation has been implicated in breast cancer and osteoporosis. ERα overexpression or mutations can lead to oncogenic effects in breast cancer making it a prominent therapeutic target. Drugs that modulate ERα activity like selective estrogen receptor modulators (SERMs) are used in breast cancer treatment. In osteoporosis ERα is related to bone density regulation with its activity affecting bone resorption and formation. Relationships between ERα and other proteins such as those involved in hormone signaling pathways impact these disease mechanisms.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3 (PubMed : 17922032). Maintains neuronal survival in response to ischemic reperfusion injury when in the presence of circulating estradiol (17-beta-estradiol/E2) (By similarity).. Isoform 3. Involved in activation of NOS3 and endothelial nitric oxide production (PubMed : 21937726). Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full-length receptor (PubMed : 10970861). Binds to ERE and inhibits isoform 1 (PubMed : 10970861).
See full target information ESR1 pS118

文献 (26)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 11:451 PubMed41057309

2025

Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Fang Yang,Zhao-Jing He,Han-Hsi Kuo,Yu-Yu Lin,Cheorl-Ho Kim,Huei-Yu Cai,Chi-Long Chen,Michael Hsiao,Ying-Chung Chen,Peter Mu-Hsin Chang,Yu-Chan Chang

Journal of experimental & clinical cancer research : CR 43:173 PubMed38898487

2024

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jiawei Zhang,Junjun Liu,Yali Yue,Lei Wang,Qunye He,Shuyi Xu,Junyan Li,Yunji Liao,Yu Chen,Shusheng Wang,Yueqing Xie,Baohong Zhang,Yanlin Bian,Dimiter S Dimitrov,Yunsheng Yuan,Jianwei Zhu

Biology 12: PubMed37998017

2023

Acetylcholine, Another Factor in Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Juan P Muñoz,Gloria M Calaf

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2302561 PubMed37897317

2023

Mammary Microvessels are Sensitive to Menstrual Cycle Sex Hormones.

Applications

Unspecified application

Species

Unspecified reactive species

Carmen Moccia,Marta Cherubini,Marina Fortea,Akinola Akinbote,Prasanna Padmanaban,Violeta Beltran-Sastre,Kristina Haase

Clinical cancer research : an official journal of the American Association for Cancer Research 29:866-877 PubMed36269797

2022

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.

Applications

Unspecified application

Species

Unspecified reactive species

Andrés Elía,Leo Saldain,Silvia I Vanzulli,Luisa A Helguero,Caroline A Lamb,Victoria Fabris,Gabriela Pataccini,Paula Martínez-Vazquez,Javier Burruchaga,Ines Caillet-Bois,Eunice Spengler,Gabriela Acosta Haab,Marcos Liguori,Alejandra Castets,Silvia Lovisi,María F Abascal,Virginia Novaro,Jana Sánchez,Javier Muñoz,José M Belizán,Martín C Abba,Hugo Gass,Paola Rojas,Claudia Lanari

Nucleic acids research 50:10230-10248 PubMed36124682

2022

Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zao-Zao Zheng,Lin Xia,Guo-Sheng Hu,Jun-Yi Liu,Ya-Hong Hu,Yu-Jie Chen,Jia-Yin Peng,Wen-Juan Zhang,Wen Liu

The Journal of neuroscience : the official journal of the Society for Neuroscience 42:7969-7983 PubMed36261268

2022

History of Previous Midlife Estradiol Treatment Permanently Alters Interactions of Brain Insulin-like Growth Factor-1 Signaling and Hippocampal Estrogen Synthesis to Enhance Cognitive Aging in a Rat Model of Menopause.

Applications

Unspecified application

Species

Unspecified reactive species

Nina E Baumgartner,Shannon M McQuillen,Samantha F Perry,Sangtawan Miller,Matthieu J Maroteaux,Robert B Gibbs,Jill M Daniel

Molecular and cellular biology 42:e0019122 PubMed36036613

2022

GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression.

Applications

Unspecified application

Species

Unspecified reactive species

Rebecca M Reese,Kyle T Helzer,Kaelyn O Allen,Christy Zheng,Natalia Solodin,Elaine T Alarid

Molecular metabolism 45:101149 PubMed33352311

2020

Crosstalk between the muscular estrogen receptor α and BDNF/TrkB signaling alleviates metabolic syndrome via 7,8-dihydroxyflavone in female mice.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenlei Zhao,Fan Xue,Yanpei Gu,Jianxin Han,Yingxian Jia,Keqiang Ye,Ying Zhang

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:15991-16002 PubMed33067917

2020

Phosphorylation site S122 in estrogen receptor α has a tissue-dependent role in female mice.

Applications

Unspecified application

Species

Unspecified reactive species

Claes Ohlsson,Karin L Gustafsson,Helen H Farman,Petra Henning,Vikte Lionikaite,Sofia Movérare-Skrtic,Klara Sjögren,Anna E Törnqvist,Annica Andersson,Ulrika Islander,Angelina I Bernardi,Matti Poutanen,Pierre Chambon,Marie K Lagerquist
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com